DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20161781

Effectiveness of metoclopramide in preventing the incidence of post-operative nausea and vomiting in lower-segment caesarean section

Rashmi ., Shivanand PT, Manjunath ML

Abstract


Background:The common and distressing symptoms which follow anaesthesia and surgery are pain, nausea and vomiting.  Nausea and vomiting are the most common side effects in the post- anaesthesia care unit. But post-operative nausea and vomiting have received less attention, though there are extensive literature, data are frequently difficult to interpret and compare. Therefore, the present study was undertaken to investigate the efficacy and safety of IV Metoclopramide as prophylaxis for postoperative nausea and vomiting in lower-segment caesarean section (LSCS) under spinal anaesthesia.

Methods: After institutional approval and informed consent fifty ASA I and II patients undergoing non-emergent LSCS taken for study. The patients received IV Metoclopramide 10 mg. Anaesthetic management was standardized. The incidence of vomiting and retching as number of episodes was studied. Nausea was graded depending on the severity and data derived.

Results: The mean episodes of emesis, nausea and retching at different postoperative duration were recorded. 64% patients experienced emesis at 1 hour. The incidence of nausea was more (56%) at 1 hour. 52 % of patients experienced retching at 1 hour whereas, 64% at 2 hour of postoperative.

Conclusions: Injection of Metoclopramide (10 mg) decreased the incidence of PONV as the side effect with this drug was minimal.


Keywords


PONV, Antiemetic Drug, Metoclopramide, Emesis, Nausea, Retching

Full Text:

PDF

References


Craigo PA. Paul A: Gastrointestinal physiology: aspiration of gastric contents; postoperative nausea and vomiting. Chapter 21. Collins VI: Physiology and pharmacological bases of anaesthesia. 1st eds. Baltimore Williams and Wilkins; 1996:361-94.

Watcha MF, White PF. Postoperative nausea and vomiting. Anaesthesiology. 1992;77:162-84.

Bunce KT, Tyers ME. The role of 5-HT in postoperative nausea and vomiting. Br J Anaesth. 1992;69:60S5-62S.

Rowbotham DJ. Current management of postoperative nausea and vomiting. Br J Anaesth. 1992;69:60S-62S.

Patel RI, Hanrallah RS. Anaesthetic complications following pediatric ambulatory surgery. Anaesthesiology. 1988;69:1009-12.

Bodner M, White PF. Antiemetic efficacy of ondansetron after outpatient laparoscopy. Anesth Analg. 1991;73:250-4.

Leeser J, Lip H. Prevention of postoperative nausea and vomiting using ondansetron, a new selective, 5-HT3 receptor antagonist. Anesth Analg. 1991;72:751-5.

Alon E, Himmelseher S. Ondansetron in the treatment of postoperative vomiting: a randomized double-blind comparison with droperidol and metoclopramide. Anesth Analg. 1992;75:561-5.

Furst SR, Rodarte A. Prophylactic antiemetic treatment with ondansetron in children undergoing tonsillectomy. Anaesthesiology. 1994;81:799-803.

Roy S, Rudra A. Ondansetron: a new antiemetic to reduce postoperative nausea and vomiting after mastoidectomy. Ind J Anaesth. 1996;44:113-7.

Van Den Berg AA. Comparison of ondansetron and prochlorperazine for the prevention of nausea and vomiting after adenotonsillectomy. Br J Anaesth. 1996;76:447-51.

Ahamed SM, Khan RM, Bano S: Prevention of emesis following strabismus surgery by ondansetron. Ind J Anaesthesia. 1997;40:17-20.

Alexander R, Fennelly M. Comparison of ondansetron, metoclopramide and placebo as premedicants to reduce nausea and vomiting after major surgery. Anaesthesia. 1997;52:695-703.

Saha S, Biswas AK. Efficacy of preoperative ondansetron in the prevention or minimising the incidence of postoperative nausea and vomiting. Ind J Anaesth. 1997;41:23-5.